Edition:
United Kingdom

Shanghai Shyndec Pharmaceutical Co Ltd (600420.SS)

600420.SS on Shanghai Stock Exchange

10.69CNY
23 Feb 2018
Change (% chg)

¥-0.05 (-0.47%)
Prev Close
¥10.74
Open
¥10.76
Day's High
¥10.76
Day's Low
¥10.63
Volume
2,647,152
Avg. Vol
5,496,743
52-wk High
¥18.50
52-wk Low
¥10.10

Latest Key Developments (Source: Significant Developments)

Shanghai Shyndec Pharmaceutical's Prelim 2017 Net Profit Up 4.3 Pct Y/Y
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>::SAYS PRELIM 2017 NET PROFIT UP 4.3 PERCENT Y/Y AT 497.4 MILLION YUAN ($77.71 million).  Full Article

Shanghai Shyndec Pharmaceutical announces change of president
Monday, 15 Jan 2018 

Jan 15(Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says Zhou Bin resigned from president .Says it appoints Yang Jun as new president of the company .  Full Article

Shanghai Shyndec Pharmaceutical unit receives GMP certificate
Friday, 12 Jan 2018 

Jan 12 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says Shantou-based pharmaceutical unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration and the valid period is until Jan. 3, 2023 .Certificate issued to unit's products including troche, hard capsule and granula.  Full Article

Shanghai Shyndec Pharmaceutical unit receives GMP certificate
Monday, 8 Jan 2018 

Jan 8(Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says its 55 percent-owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration .Certificate issued to freeze-dried powder injection manufactured by the unit and the valid period is until Dec. 12, 2022.  Full Article

Shanghai Shyndec Pharmaceutical injects capital of 50 mln yuan into pharmaceutical unit
Tuesday, 2 Jan 2018 

Jan 2(Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says co injects capital of 50 million yuan into co's Wuhan-based pharmaceutical unit and raises stake in the unit to 96.95 percent from 96.16 percent .  Full Article

Shanghai Shyndec Pharmaceutical's 9-month net profit up 16.1 pct y/y
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says 9-month net profit up 16.1 percent y/y at 446.0 million yuan ($67.22 million).  Full Article

Shanghai Shyndec Pharmaceutical's H1 net profit up, plans product upgrade project
Thursday, 17 Aug 2017 

Aug 17 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says its H1 net profit up 23.3 percent y/y at 357.3 million yuan ($53.56 million).Says it plans to invest in product upgrade project with total investment of about 1.45 billion yuan.  Full Article

Shanghai Shyndec Pharmaceutical unit gets approval for clinical trial
Friday, 19 Aug 2016 

Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says its unit received approval from China Food and Drug Administration for clinical trial for capsule of an immune inhibitor.  Full Article

Shanghai Shyndec Pharma cuts share issue size in acquisition proposal
Monday, 27 Jun 2016 

Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS> :Says it cuts share issue size in asset acquisition proposal to 100 million yuan ($15.04 million) from 1.9 billion yuan previously.  Full Article

Shanghai Shyndec Pharmaceutical to pay 2015 dividend on June 24
Monday, 20 Jun 2016 

Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>: Says it will use undistributed profits to pay a cash dividend of 0.5 yuan (pre-tax) per 10 shares to shareholders of record on June 23 for 2015 .Says the company's shares will be traded ex-dividend on June 24 and the dividend will be paid on June 24.  Full Article

BRIEF-Shanghai Shyndec Pharmaceutical unit obtains high-tech enterprise recognition and to enjoy tax preference

* Says its wholly owned unit was recognized as high-tech enterprise, and to enjoy a tax preference of 15 percent for three years from 2017 to 2019